CIK: 0000200406
Total Value
$554.63B
Holdings
17
Latest Filing
Feb 13, 2026
Quarterly Filings
10
| Quarter | Holdings | Total Value | Report Period | Date Filed | Actions |
|---|---|---|---|---|---|
Q4 2025 Latest | 17 | $554.63B-0.1% | Dec 31, 2025 | Feb 13, 2026 | |
Q4 2025 | 17 | $555.05B+10.2% | Dec 31, 2025 | Mar 18, 2026 | |
Q3 2025 | 20 | $503.70B+50.8% | Sep 30, 2025 | Nov 13, 2025 | |
Q2 2025 | 20 | $334.10B-2.3% | Jun 30, 2025 | Jul 22, 2025 | |
Q1 2025 | 20 | $341.87B-11.5% | Mar 31, 2025 | May 7, 2025 | |
Q4 2024 | 20 | $386.13B-9.6% | Dec 31, 2024 | Feb 13, 2025 | |
Q3 2024 | 20 | $427.33B+6.7% | Sep 30, 2024 | Nov 13, 2024 | |
Q2 2024 | 20 | $400.67B-90.9% | Jun 30, 2024 | Aug 9, 2024 | |
Q1 2024 | 22 | $4.41T+0.6% | Mar 31, 2024 | May 10, 2024 | |
Q4 2023 | 23 | $4.39T | Dec 31, 2023 | Feb 14, 2024 |
23K shares
-13.7%
Protagonist Therapeutics Inc.
2.45M shares
$213.91B
38.6%
Nanobiotix S.A.
5.62M shares
$130.02B
23.4%
Rapport Therapeutics, Inc.
1.78M shares
$54.14B
9.8%
MeiraGTx Holdings plc
6.64M shares
$52.80B
9.5%
CVRx, Inc.
4.02M shares
$28.58B
5.2%
Contineum Therapeutics Inc.
1.98M shares
$22.62B
4.1%
Legend Biotech Corporation
815K shares
$17.71B
3.2%
Xencor, Inc.
748K shares
$11.45B
2.1%
Procept BioRobotics Corporation
358K shares
$11.26B
2.0%
Fate Therapeutics, Inc.
3.38M shares
$3.32B
0.6%
CIK
0000200406
Latest Report Period
Dec 31, 2025
Report Type
13F-HR
Accession Number
0000904454-26-000111